SCHEMBL6013688

SCHEMBL6013688

CCOc1ccc(-c2ccccc2C(N)=O)cc1OCC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MKNK1 Q9BUB5 1/20 0.51
▸ MKNK2 Q9HBH9 1/20 0.51
▸ LMNA P02545 3/20 0.50
▸ BCAT2 O15382 1/20 0.50
▸ CTSA P10619 1/20 0.48
▸ PTPN11 Q06124 1/20 0.48
▸ MAPK1 P28482 2/20 0.48
▸ TNF P01375 1/20 0.47
▸ POLB P06746 1/20 0.46
▸ CASP6 P55212 1/20 0.46
▸ PTPRC P08575 1/20 0.46
▸ CHEK1 O14757 1/20 0.45
▸ RAB9A P51151 1/20 0.44
▸ ALOX5AP P20292 1/20 0.44
▸ FEN1 P39748 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ LTB4R2 Q9NPC1 1/20 0.44
▸ MAPT P10636 2/20 0.43
▸ MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7762502 0.82 BCAT2 (0.56) MKNK1MKNK2LMNABCAT2CTSA
SCHEMBL4966792 0.81 BCAT2 (0.59) LMNABCAT2RAB9AALDH1A1L3MBTL1
SCHEMBL23041012 0.80 MAPT (0.53) LMNABCAT2MAPK1ALDH1A1L3MBTL1
SCHEMBL20928284 0.80 SLC6A3 (0.57) LMNAMAPK1POLBCHEK1ALDH1A1
SCHEMBL11021677 0.77 PGR (0.50) LMNAMAPK1POLBPTPRCRAB9A
Ethenzamide SCHEMBL25624 0.76 MAPT (0.68) LMNAMAPK1L3MBTL1MAPTMEN1
Ethenzamide SCHEMBL27612766 0.76 MAPT (0.68) LMNAMAPK1L3MBTL1MAPTMEN1
SCHEMBL5724135 0.75 PARP1 (0.56) LMNABCAT2CTSAMAPK1POLB
Ethenzamide SCHEMBL22163775 0.75 MAPT (0.66) LMNAMAPK1L3MBTL1MAPTMEN1
Ethenzamide SCHEMBL4379591 0.75 MAPT (0.66) LMNAMAPK1L3MBTL1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1638556-A1 2-AMINOBENZOTHIAZOLES AS CB1 RECEPTOR INVERSE AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2006-03-29 — — EP disclosed
WO-2005000301-A1 2-AMINOBENZOTHIAZOLES AS CB1 RECEPTOR INVERSE AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2005-01-06 — — WO disclosed
Send feedback